
Sponsored
July 15, 2026
Greetings Readers,
A Nasdaq diagnostics company trading at roughly a $6 million market cap with a low float of just 3.87 million shares is executing on multiple fronts: FDA-registered device launched in the UK, institutional wellness programs deploying the device for real-world validation, cannabis breathalyzer in development, and CAR T/CAR NK patents secured through 2040 in China and Hong Kong.
The company is expanding into the UK, partnering with wellness organizations for first responder programs, developing cannabis impairment detection devices, and securing patent protection through 2040 for bispecific CAR T and CAR NK technology in China and Hong Kong.
Now add a public float of just 3.87 million shares, multiple active partnerships, and a pipeline spanning consumer diagnostics to breakthrough cell therapy platforms, and you'll see exactly why this micro-cap profile is demanding attention.
Here's what's happening with this micro-cap Nasdaq name:
Avalon GloboCare is a precision diagnostics and biotechnology company developing consumer health technologies and next-generation cellular therapies. The company's lead commercial asset, KetoAir™️, is an FDA-registered Class I medical device designed for metabolic health monitoring through breath acetone measurement.
KetoAir™️ is engineered to provide real-time insights into fat metabolism and ketosis, helping users optimize ketogenic diets for weight loss, athletic performance, and therapeutic applications. Its nanosensor technology delivers lab-quality measurements through a handheld breathalyzer connected to mobile apps.
And based on multiple catalysts now taking shape, ALBT has secured a top position on my watchlist heading into 2026.
Avalon GloboCare has completed a major strategic acquisition, purchasing RPM Interactive, a generative AI publishing and software company, in a $19.5 million all-stock transaction. As a result of this deal, the Company believes its stockholders' equity now exceeds the $2.5 million minimum required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1).
Under the terms of the merger agreement, RPM was merged into a newly formed wholly owned subsidiary, Avalon Quantum AI, LLC, and Avalon issued 19,500 shares of Series E Non-Voting Convertible Preferred Stock valued at $1,000 per share, convertible into common stock at $1.50 per share beginning May 12, 2026, subject to customary conditions and limits.
The acquisition brings RPM's Catch-Up SaaS platform into Avalon's ecosystem, a fully automated generative AI system that sources relevant clips, generates human-like AI commentary, creates engaging on-screen avatars, and publishes finished content across major platforms. Avalon plans to leverage this technology to support and amplify marketing initiatives for KetoAir and its broader consumer health portfolio beginning early next year.
As part of the transaction, RPM's CEO Michael Mathews has been appointed to Avalon's Board of Directors, bringing more than two decades of experience in AI-enabled systems and digital media growth strategies.
Source for Full PR: Avalon GloboCare Corp.
This acquisition may represent a turning point for ALBT as it brings several important dynamics into play:
More on each of these in a moment.
Avalon is a commercial-stage diagnostics company focused on advancing precision consumer health technology. The company's flagship product, KetoAir™️, is an FDA-registered breathalyzer designed for continuous metabolic monitoring through breath acetone detection.
Traditional ketone monitoring requires invasive blood tests or unreliable urine strips. Many users struggle with accuracy and consistency, leading to poor adherence and suboptimal outcomes.
Avalon aims to solve this.
KetoAir™️ has a commercial-ready profile supported by FDA registration and active deployment. The device measures breath acetone concentration (BrAce), a biomarker of fat metabolism that correlates with nutritional ketosis. Breath testing is non-invasive, repeatable, and provides instant feedback.
Key distinctions include:
KetoAir™️ is being used in structured programs for first responders, athletes, and metabolic health clients, helping them track real-time physiological changes.
Nevada First Responder Wellness Initiative
In August 2025, Avalon launched the "Nevada POOL/PACT Holistic Health Reset" program with Saga Health and SpecialtyHealth, Inc. Fifty first responders are using KetoAir™️ over a four-month initiative focused on metabolic, physical, and behavioral health improvements. Mid-program data shows measurable individual health progress.
UK Market Entry
On September 1, 2025, Avalon began commercial distribution of KetoAir™️ in the United Kingdom through KetoAir.uk, marking its first international market launch and demonstrating scalable global distribution.
London Health Optimization Summit
Avalon showcased KetoAir™️ at the London Health Optimization Summit on September 13–14, 2025, gaining visibility with wellness professionals and potential partners.
Avalon's expansion includes development of a cannabis breathalyzer using the same nanosensor technology powering KetoAir™️.
Concurrently, Avalon has secured CAR T and CAR NK patents through 2040 in China and Hong Kong, covering bispecific anti-CD19 x CD22 technology.
The Q3 developments validate Avalon’s ability to scale commercially while building high-value IP assets. The UK launch demonstrates international scalability, the Nevada program provides real-world outcome data, the cannabis breathalyzer targets a regulatory compliance market, and the CAR T/CAR NK patents offer long-term licensing opportunities.
With just 3.87M shares in the float, ALBT could see amplified volatility as new catalysts emerge.
UK distribution is only the beginning — additional European markets could follow with minimal incremental cost, each representing new revenue channels.
The Nevada program provides replicable proof-of-concept for municipal, corporate, and healthcare system contracts.
Cannabis legalization is creating urgent demand for real-time impairment testing. A validated breath solution could become a major commercial opportunity.
Patents through 2040 provide licensing optionality in major Asian markets, representing long-term non-dilutive revenue potential.
ALBT is now on the active watchlist. As developments emerge, updates will follow here.
Add Avalon GloboCare Corp. (NASDAQ: ALBT) to your radar.
Don't miss our next early stock alert.
Join our SMS list and get real time picks sent straight to your phone the moment we release them.
Fast, free, zero spam. Opt out anytime.
By joining, you agree to receive recurring SMS alerts from TopStocks. Message and data rates may apply. Reply STOP to unsubscribe.
MASTER LEGAL DISCLAIMER
Last Updated: Nov 30, 2025
Publisher: Relqo Media LLC (Wyoming, United States)
Subject Company: Avalon GloboCare Corp. (ALBT)
IMPORTANT SUMMARY — PLEASE READ FIRST
This website and all affiliated digital materials are published by Relqo Media LLC, a Wyoming marketing agency that has been compensated in cash by YachtXotics Enterprises Inc. and Uptic Analytics LLC to produce and distribute promotional content regarding Avalon GloboCare Corp. (NASDAQ, ALBT). This communication is a paid advertisement, not a research report, not investment advice, and not an independent publication. Relqo Media is not a broker-dealer, investment adviser, or securities analyst. Investing in small-cap or microcap securities is highly speculative and may result in the complete loss of your investment. All viewers are strongly urged to consult with a licensed investment professional and perform their own due diligence.
1. NATURE AND INTENT OF THIS COMMUNICATION
Relqo Media LLC is a for-profit marketing agency engaged in paid promotional campaigns for public companies. The content we create is strictly commercial and is intended to generate temporary public awareness, visibility, and short-term market attention for the featured company. This material is not impartial. All readers should interpret our content as a paid commercial advertisement and not as an editorial, research article, or independent analysis. We produce advertisements, not investment research. These communications are not designed to provide factual evaluations of the company's business operations or investment merit.
2. COMPENSATION FOR Avalon GloboCare Corp. (ALBT)
Relqo Media LLC has been contracted by YachtXotics Enterprises Inc. and Uptic Analytics LLC to provide investor awareness and advertising services for Avalon GloboCare Corp. (NASDAQ, ALBT). These arrangements involve monetary compensation in exchange for creating and distributing promotional content across multiple digital channels.
Relqo Media LLC has received or will receive the following compensation for ALBT promotional services:
YachtXotics Enterprises Inc., Uptic Analytics LLC, and or their affiliates may own, acquire, or sell securities of ALBT before, during, or after the promotional period. Uptic Analytics LLC currently owns shares of ALBT, which represents an additional material conflict of interest. Any ownership interests, whether past, present, or future, must be assumed to influence the promotional content distributed for this campaign. All promotional materials produced by Relqo Media LLC regarding ALBT should be viewed as biased, financially motivated content created for the benefit of the paying entities.
Relqo Media LLC does not represent itself as a licensed broker-dealer, registered investment adviser, or financial analyst. Nothing in our content should be interpreted as investment advice, an offer to buy or sell securities, or a recommendation to engage in any investment activity.
Readers should perform independent due diligence, consult with licensed financial professionals, and assume that any statements made about ALBT are materially influenced by compensation and the ownership interests of the paying clients.
Neither Relqo Media LLC, YachtXotics Enterprises Inc., nor Uptic Analytics LLC guarantee the accuracy, timeliness, or completeness of the information provided. All parties disclaim any liability for investment losses that may occur as a result of reliance on our promotional materials.
3. INTENDED AUDIENCE
These Communications are directed solely to U.S.-based, self-directed investors who understand the risks of investing in microcap and Nasdaq-listed securities. The content is not intended for children, seniors, retirement accounts, or individuals with limited experience in securities trading. These Communications are not intended to guide investment for long-term portfolio management or financial planning purposes.
4. NO ENDORSEMENT OR VERIFICATION OF COMPANY CLAIMS
Relqo Media LLC does not, and has not, independently verified, investigated, audited, or substantiated any statements, representations, or claims made by the featured company, its officers, directors, employees, affiliates, agents, press releases, marketing materials, or any third-party sources.
Any and all information regarding Avalon GloboCare Corp. (NASDAQ: ALBT)—including but not limited to business descriptions, operational updates, clinical trial progress, scientific data, partnerships, revenue projections, market opportunity estimates, or strategic plans—should be assumed to be unverified, unaudited, incomplete, potentially inaccurate, and subject to change without notice.
We make no warranties or representations as to the truthfulness, accuracy, reliability, or completeness of such information, and you should not interpret our publication of these statements as an endorsement or confirmation of their validity.
You should not rely on any company-provided claims, projections, or forward-looking statements for the purpose of making an investment decision. All such statements may be speculative, overstated, selectively presented, or based on assumptions that may never materialize.
If you choose to invest, you do so entirely at your own risk, and you should conduct thorough, independent due diligence—including reviewing SEC filings, consulting licensed investment professionals, and obtaining independent verification of any material facts—before making any investment decision.
5. MARKET INFLUENCE AND TRADING PATTERN EXPECTATION
Historically, promotional campaigns for microcap and small-cap securities—particularly those driven by paid advertising—often cause temporary, artificial, and unsustainable increases in share price and trading volume. These movements are typically fueled by short-term speculative interest, promotional circulation, algorithmic trading activity, and momentum-based retail buying rather than any change in the underlying business, operations, or financial condition of the company.
You should assume and expect that:
Past market behavior shows that such promotional price spikes are frequently followed by steep losses, which can be rapid and irreversible. If you purchase shares during or shortly after a promotional period, you should be prepared for the high probability of losing a substantial portion, or all, of your investment.
By engaging with our content, you acknowledge and agree that you fully understand the speculative, volatile, and high-risk nature of securities subject to promotional activity, and you will not hold Relqo Media LLC responsible for any losses resulting from such trading patterns.
6. NO RELIANCE – INVESTOR RESPONSIBILITY
The burden of research, verification, and risk assessment rests entirely with you, the reader. All content produced and distributed by Relqo Media LLC is promotional in nature and should not be the basis for any investment decision. We are not responsible for your interpretation or use of the information contained herein.
You are solely responsible for:
We make no warranties or representations as to the accuracy, completeness, timeliness, or reliability of any information presented. Any data, figures, or statements regarding the featured company's business, market opportunity, future performance, or partnerships may be incomplete, outdated, or incorrect. You should assume that certain information is based on third-party sources we have not independently verified.
By viewing our materials, you agree that:
7. FORWARD-LOOKING STATEMENTS, ASSUMPTIONS, AND ACCURACY NOTICE
Our materials may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as well as other predictive or aspirational language regarding future events, performance, or results. Words such as "anticipates," "expects," "intends," "plans," "believes," "may," "will," "should," "could," "projects," "estimates," "potential," and similar expressions are intended to identify such statements. These statements are inherently uncertain, based on current expectations, estimates, and assumptions that may prove to be incorrect, incomplete, or no longer applicable at the time you read them.
Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied. Such factors include, but are not limited to: changes in market conditions, regulatory decisions, the outcome of clinical trials, competitive pressures, the availability of financing, and broader economic or geopolitical developments.
Additionally, some information presented in our content is derived from third-party sources, company press releases, or statements from officers, directors, or affiliates of the featured company. We do not independently verify or guarantee the accuracy, completeness, or timeliness of such information. Any claim, projection, or forward-looking statement should be considered purely speculative and potentially outdated..
You should not place undue reliance on forward-looking statements or assume that they will prove to be accurate. Relqo Media LLC undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events, changes in circumstances, or the emergence of new information, except as required by law.
8. INFORMATION SOURCING, BIAS, AND ACCURACY
We use publicly available information including company websites, press releases, and promotional materials supplied by paying clients or related parties. We do not verify or validate this data.
Assume all information presented by Relqo Media is:
9. OWNERSHIP AND TRADING CONFLICTS
Relqo Media LLC, its contractors, members, and affiliates may hold or acquire shares in the companies we promote, including ALBT. We may buy or sell such shares without prior notice. These transactions may occur before, during, or after a promotional campaign and may affect market pricing. We are not obligated to update readers on our trading activity or affiliate holdings.
10. MARKETING TOOLS, DATA COLLECTION, AND USER CONSENT
We use a range of outreach and promotional tools, including:
By engaging with our content, you consent to receive ongoing marketing communications. You may unsubscribe, but your data may be retained for audit or compliance purposes. Please refer to our Privacy Policy for further details.
11. ADVERTISING LAW COMPLIANCE
Relqo Media LLC produces promotional content in accordance with the advertising disclosure standards set forth by the Federal Trade Commission (FTC) and the SEC's interpretations of sponsored investment-related communications.
We make good-faith efforts to disclose all:
We do not provide investment recommendations under any regulatory framework including, but not limited to, SEC Regulation Analyst Certification, FINRA Rule 2210, or Regulation Best Interest.
12. NON-U.S. USERS
This material is intended solely for distribution within the United States. If you are accessing this site from outside the U.S., you are responsible for complying with your country's laws. Relqo Media disclaims liability for access from non-U.S. jurisdictions where investor promotion, marketing, or solicitation of securities is restricted or prohibited.
13. DISCLAIMER OF WARRANTIES AND LIMITATION OF LIABILITY
All content is provided "as-is" and without warranties of any kind, either express or implied. Relqo Media LLC disclaims any and all liability for:
Total liability for any claim shall not exceed one hundred dollars ($100).
14. LEGAL GOVERNANCE AND DISPUTE RESOLUTION
All matters arising out of this disclaimer shall be governed by the laws of the State of Wyoming. You agree that any dispute shall be resolved exclusively through binding arbitration under the rules of the American Arbitration Association, to be held in Sheridan County, Wyoming. Class action claims and group arbitration are expressly prohibited.
15. NON-SOLICITATION AND GEOGRAPHIC LIMITATIONS
Nothing in our content constitutes a general solicitation or a personal securities recommendation. If you reside in a jurisdiction where such communications are unlawful, you must exit this site and discontinue engagement with our content.
16. FINAL NOTICE – ACCEPTANCE OF TERMS
We reserve the right to update this Disclaimer at any time without notice. Your continued use of our services or content constitutes acceptance of the most recent version.
If you do not accept all terms of this disclaimer in full, you must:
17. NO RELIANCE
By viewing or engaging with this content, you agree that:
© 2024 Relqo Media LLC. All Rights Reserved.
Legal Contact: 📧 support@topstocks.com
Mailing Address: 1309 Coffeen Ave Ste 1200, Sheridan, WY 82801
Affiliate Disclosure: Relqo Media LLC owns and operates TopStocks.com and all affiliated digital properties.